Amidine- and Amidoxime-Substituted Heterocycles: Synthesis, Antiproliferative Evaluations and DNA Binding

Molecules. 2021 Nov 22;26(22):7060. doi: 10.3390/molecules26227060.

Abstract

The novel 1,2,3-triazolyl-appended N- and O-heterocycles containing amidine 4-11 and amidoxime 12-22 moiety were prepared and evaluated for their antiproliferative activities in vitro. Among the series of amidine-substituted heterocycles, aromatic diamidine 5 and coumarine amidine 11 had the most potent growth-inhibitory effect on cervical carcinoma (HeLa), hepatocellular carcinoma (HepG2) and colorectal adenocarcinoma (SW620), with IC50 values in the nM range. Although compound 5 was toxic to non-tumor HFF cells, compound 11 showed certain selectivity. From the amidoxime series, quinoline amidoximes 18 and 20 showed antiproliferative effects on lung adenocarcinoma (A549), HeLa and SW620 cells emphasizing compound 20 that exhibited no cytostatic effect on normal HFF fibroblasts. Results of CD titrations and thermal melting experiments indicated that compounds 5 and 10 most likely bind inside the minor groove of AT-DNA and intercalate into AU-RNA. Compounds 6, 9 and 11 bind to AT-DNA with mixed binding mode, most probably minor groove binding accompanied with aggregate binding along the DNA backbone.

Keywords: CD spectroscopy; DNA binding; amidine; amidoxime; antiproliferative activity; fluorescence; thermal denaturation.

MeSH terms

  • A549 Cells
  • Antineoplastic Agents / chemical synthesis
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology
  • Cell Proliferation*
  • DNA, Neoplasm* / chemistry
  • DNA, Neoplasm* / metabolism
  • HeLa Cells
  • Hep G2 Cells
  • Humans
  • Intercalating Agents* / chemical synthesis
  • Intercalating Agents* / chemistry
  • Intercalating Agents* / pharmacology
  • Neoplasms* / drug therapy
  • Neoplasms* / metabolism
  • Oximes / chemistry*

Substances

  • Antineoplastic Agents
  • DNA, Neoplasm
  • Intercalating Agents
  • Oximes
  • amidoxime